Last reviewed · How we verify

NCT05498818

The Effects of Synaquell on Brain Function of Ice Hockey Players

Completed NA Last updated 9 January 2024
What this trial tests

NA trial testing Synaquell in Healthy in 81 participants. Completed in 14 March 2023.

Timeline
3 November 2022
Primary endpoint
14 March 2023
14 March 2023

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment81
Start date3 November 2022
Primary completion14 March 2023
Estimated completion14 March 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 13 to 19, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is being done to investigate the dietary supplement, Synaquell (TM), for effects on brain function in youth ice hockey players.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Synaquell

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05498818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing